Magnesium Sulfate Use in Pregnancy for Preeclampsia Prophylaxis and Fetal Neuroprotection
Magnesium sulfate is one of the most commonly used medications in obstetrics, most notably for the prevention of eclamptic seizures and fetal neuroprotection of the extremely preterm neonate. Pharmacokinetic and pharmacodynamic studies have demonstrated a variety of IV and IM regimens are effective for these indications. Existing models and data can be used to tailor treatment regimens to increase coverage in poor resource areas, maximize efficacy and minimize toxicity for patients of different weights and renal function. (Source: Obstetrics and Gynecology Clinics)
Source: Obstetrics and Gynecology Clinics - February 22, 2023 Category: OBGYN Authors: Kathleen F. Brookfield, Osinakachukwu Mbata Source Type: research
Obstetric Indications for Progestin Therapy
Specifically, meta-analyses of randomized trials demonstrate that vaginal progesterone reduces the risk of preterm birth in selected high-risk singleton pregnancies. 17-OHPC may also reduce the risk of recurrent preterm birth in singletons. Finally, one trial suggests that vaginal progesterone may also be beneficial in improving live birth rates in singletons with prior miscarriages and early pregnancy bleeding. (Source: Obstetrics and Gynecology Clinics)
Source: Obstetrics and Gynecology Clinics - February 22, 2023 Category: OBGYN Authors: Rupsa C. Boelig Source Type: research
Aspirin and Pravastatin for Preeclampsia Prevention in High-Risk Pregnancy
Preeclampsia is a hypertensive disorder of pregnancy affecting up to 8% of pregnancies. It is associated with significant neonatal and maternal morbidities and mortality. Although its pathogenesis is not completely understood, abnormal placentation resulting in imbalance in angiogenic factors, increased inflammation, and endothelial dysfunction are thought to be key pathways in the development of the disease. Administration of low-dose aspirin is recommended by professional societies for the prevention of preeclampsia in high-risk individuals. In this review, we summarize the evidence behind the use of low-dose aspirin and...
Source: Obstetrics and Gynecology Clinics - February 22, 2023 Category: OBGYN Authors: Joe Eid, Kara M. Rood, Maged M. Costantine Source Type: research
Antenatal Steroids and Tocolytics in Pregnancy
Preterm birth, typically defined as birth between 20 0/7 weeks and 36 6/7 weeks of gestation, is a major cause of neonatal morbidity, and rates of preterm birth continue to rise. Antenatal corticosteroids have demonstrated benefit for reduction of morbidities and mortality associated with preterm birth, with few observed maternal risks. As such, antena tal corticosteroids have become the standard of care for treating pregnant people at risk of preterm birth. Tocolytics may be beneficial in temporarily slowing uterine contractions to prolong pregnancy long enough for the administration of corticosteroids or stabilization...
Source: Obstetrics and Gynecology Clinics - February 22, 2023 Category: OBGYN Authors: Kelsey Pinson, Cynthia Gyamfi-Bannerman Source Type: research
Medications for Managing Preexisting and Gestational Diabetes in Pregnancy
Persons with gestational and pregestational diabetes during pregnancy may require pharmacologic agents to achieve pregnancy glycemic targets, and the available medications for use in pregnancy are limited. Insulin is the only FDA-approved medication for use in pregnancy and has the greatest evidence for safety and efficacy. Metformin and glyburide are the most commonly used oral agents in pregnancy. Understanding each medication ’s unique pharmacokinetics, potential side effects, fetal or childhood risks, gestational age of medication initiation and patient’s diabetes care barriers are important aspects of shared decis...
Source: Obstetrics and Gynecology Clinics - February 22, 2023 Category: OBGYN Authors: Michaela Rickert, Aaron B. Caughey, Amy M. Valent Source Type: research
Antihypertensives in Pregnancy
This article summarizes current guidelines on the diagnosis and treatment of hypertension in pregnancy and provides an in-depth guide to the available safety and efficacy data for antihypertensives during pregnancy and postpartum. (Source: Obstetrics and Gynecology Clinics)
Source: Obstetrics and Gynecology Clinics - February 22, 2023 Category: OBGYN Authors: Anna E. Denoble, Sarah A. Goldstein, Christian M. Pettker Source Type: research
A Clinical Review of the Use of Common Psychiatric Medications in Pregnancy
Psychotropic medications are commonly prescribed in pregnancy, and obstetrical providers should be informed about how and when to use them. The current narrative review addresses the use of some of the most commonly prescribed psychotropic medications —antidepressants, sedatives and hypnotics, and antipsychotic drugs. The aim is neither a complete review of psychiatric disorders in pregnancy nor all possible psychological and pharmacological treatments for mental illness around the time of pregnancy. Rather, the focus is on therapeutic consider ations for general obstetrical providers. (Source: Obstetrics and Gynecology Clinics)
Source: Obstetrics and Gynecology Clinics - February 22, 2023 Category: OBGYN Authors: Shakked Lubotzky-Gete, Lucy C. Barker, Simone N. Vigod Source Type: research
Anticoagulation Regimens in Pregnancy
This article explores current recommendations for anticoagulation therapy in pregnancy, including antepartum, intrapartum, and postpartum guidelines. The authors review various screening strategies used to assess whether a patient is an appropriate candidate for anticoagulation during pregnancy and the postpartum period. The article includes dosing regimens, optimal surveillance, and medication reversal. The authors also address the challenges of transitioning between low-molecular-weight heparin and unfractionated heparin. Finally, there is a discussion of intrapartum anticoagulation management, especially as it relates t...
Source: Obstetrics and Gynecology Clinics - February 22, 2023 Category: OBGYN Authors: Antonio Saad, Melody Safarzadeh, Megan Shepherd Source Type: research
Antibiotics in Labor and Delivery
Infections are common in obstetric care and often require specific antibiotics, depending on the infection site and prevailing organisms. Summaries of antibiotic recommendations and treatment algorithms are provided for the following conditions: routine labor, group B streptococcus prophylaxis, preterm prelabor rupture of membranes, operative vaginal delivery, cesarean delivery, obstetric anal sphincter lacerations, chorioamnionitis, postpartum endometritis, infections of the urinary tract, and bacterial endocarditis prophylaxis. (Source: Obstetrics and Gynecology Clinics)
Source: Obstetrics and Gynecology Clinics - February 22, 2023 Category: OBGYN Authors: Joanna M. Izewski, Brandon Z. Bell, David M. Haas Source Type: research
Principles of Obstetric Pharmacology
Since the recognition of pregnancy as a special pharmacokinetic population in the late 1990s, investigations have expanded our understanding of obstetric pharmacology. Many of the basic physiologic changes that occur during pregnancy impact on drug absorption, distribution, or clearance. Activities of hepatic metabolizing enzymes are variably altered by pregnancy, resulting in concentrations sufficiently different for some drugs that efficacy or toxicity may be affected. Understanding these unique pharmacologic changes will better inform our use of medications for our pregnant patients. (Source: Obstetrics and Gynecology Clinics)
Source: Obstetrics and Gynecology Clinics - February 22, 2023 Category: OBGYN Authors: Catherine S. Stika Source Type: research
Antiretrovirals for Human Immunodeficiency Virus Treatment and Prevention in Pregnancy
Safe and effective antiretroviral medications are needed during pregnancy to reduce maternal morbidity and mortality associated with untreated human immunodeficiency virus (HIV) infection and to prevent viral transmission to the infant. Pharmacokinetic studies have helped inform the appropriate dosing of antiretroviral medications during pregnancy. However, data from these studies consistently become available years after initial regulatory approvals in nonpregnant adults. In this article, the authors provide an overview of considerations in use of antiretroviral medications in pregnant people with or at risk for HIV, phar...
Source: Obstetrics and Gynecology Clinics - February 22, 2023 Category: OBGYN Authors: Kristina M. Brooks, Kimberly K. Scarsi, Mark Mirochnick Source Type: research
Antiseizure Medications in Pregnancy
Epilepsy affects up to 15 million of people assigned female at birth of childbearing age globally. Up to 65% of these people with epilepsy and gestational capacity have an unplanned pregnancy. Seizure control during pregnancy is important for both the childbearer ’s and fetus’ safety. There are multiple antiseizure medications (ASMs) that can be used to control epilepsy; however, each medication has its own teratogenic risk profile, which must be considered. The majority of these ASMs will require frequent plasma concentration monitoring during pregnancy with corresponding dosage adjustments. Dosages can be reduced bac...
Source: Obstetrics and Gynecology Clinics - February 22, 2023 Category: OBGYN Authors: Alexandra C. Moise, Elizabeth E. Gerard Source Type: research
Opioids and Opioid Use Disorder in Pregnancy
Overdose is a leading cause of pregnancy-associated morbidity and mortality in the United States. As such, all obstetric providers have a responsibility to provide evidence-based care for patients with opioid use disorder to mitigate adverse outcomes associated with substance use during pregnancy. (Source: Obstetrics and Gynecology Clinics)
Source: Obstetrics and Gynecology Clinics - February 22, 2023 Category: OBGYN Authors: Aalok R. Sanjanwala, Grace Lim, Elizabeth E. Krans Source Type: research
Analgesia in Pregnancy
Pain management during labor and delivery is complex and must balance efficacy and toxicity to both the pregnant person and the fetus. There are numerous ways to achieve safe and effective analgesia and anesthesia during labor and delivery, including neuraxial and nonneuraxial techniques. This review describes important anesthetic considerations that should be made when formulating a pain management plan and an overview of common anesthesia-related complications encountered in the obstetric population. (Source: Obstetrics and Gynecology Clinics)
Source: Obstetrics and Gynecology Clinics - February 22, 2023 Category: OBGYN Authors: Leslie Matthews, Grace Lim Source Type: research
An Overview of Antiviral Treatments in Pregnancy
Viral infections pose unique threats to pregnant persons and their infants. As the frequency of epidemics caused by novel pathogens increases, understanding pregnancy-specific considerations for antiviral treatments is critical for obstetric and nonobstetric providers alike. The use of pharmacologic therapeutics in pregnancy, which include antivirals, pathogen-specific antibodies, and vaccines, is limited due to the lack of purposeful, methodologic, pharmacometrics analyses in this special population. Our current understanding regarding dosing, safety, and efficacy stems from our knowledge of potential maternal or neonatal...
Source: Obstetrics and Gynecology Clinics - February 22, 2023 Category: OBGYN Authors: Naima T. Joseph, Jaspreet Banga, Martina L. Badell Source Type: research
